Serraino, G.F.; Bolignano, D.; Jiritano, F.; Coppolino, G.; Napolitano, D.; Zicarelli, M.; Pizzini, P.; Cutrupi, S.; Testa, A.; Spoto, B.;
et al. Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass. J. Clin. Med. 2024, 13, 2943.
https://doi.org/10.3390/jcm13102943
AMA Style
Serraino GF, Bolignano D, Jiritano F, Coppolino G, Napolitano D, Zicarelli M, Pizzini P, Cutrupi S, Testa A, Spoto B,
et al. Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass. Journal of Clinical Medicine. 2024; 13(10):2943.
https://doi.org/10.3390/jcm13102943
Chicago/Turabian Style
Serraino, Giuseppe Filiberto, Davide Bolignano, Federica Jiritano, Giuseppe Coppolino, Désirée Napolitano, Mariateresa Zicarelli, Patrizia Pizzini, Sebastiano Cutrupi, Alessandra Testa, Belinda Spoto,
and et al. 2024. "Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass" Journal of Clinical Medicine 13, no. 10: 2943.
https://doi.org/10.3390/jcm13102943
APA Style
Serraino, G. F., Bolignano, D., Jiritano, F., Coppolino, G., Napolitano, D., Zicarelli, M., Pizzini, P., Cutrupi, S., Testa, A., Spoto, B., Andreucci, M., Mastroroberto, P., & Serra, R.
(2024). Selenoprotein P-1 (SEPP1) as an Early Biomarker of Myocardial Injury in Patients Undergoing Cardiopulmonary Bypass. Journal of Clinical Medicine, 13(10), 2943.
https://doi.org/10.3390/jcm13102943
